Evidence map›Paper›PMID 20828812›Full record

ArticleBiomaterials2010

Co-administration of protein drugs with gold nanoparticles to enable percutaneous delivery.

Yongzhuo Huang, Faquan Yu, Yoon-Shin Park, Jianxin Wang, Meong-Cheol Shin, Hee Sun Chung, Victor C Yang

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 183 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Nanocarriers for Skin Applications: Where Do We Stand?Angewandte Chemie (International ed. in English) · 2022
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yongzhuo HuangShanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Hai-ke Road, Shanghai 201203, China.
Faquan Yu
Yoon-Shin Park
Jianxin Wang
Meong-Cheol Shin
Hee Sun Chung
Victor C Yang
University of Michigan–Ann Arbor · USShanghai Institute of Materia Medica · CN

Funding

PTD-Mediated Protein or Drug Delivery for Cancer TherapyR01CA114612 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI YANG, VICTOR C · 2005 to 2015
$2.5M
MION for Synchronized MRI and Drug Therapy of Brain TumorR01NS066945 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI YANG, VICTOR C · 2009 to 2010
$770k
NCI NIH HHS R01 CA114612NINDS NIH HHS R01 NS066945
6 · The paper itself

Abstract

An interesting nanoscale interfacial phenomenon mediated by gold nanoparticles (Au-NPs) was found, in that co-administration with Au-NPs enables percutaneous delivery of protein drugs. The Au-NPs with a mean size of 5 nm were revealed to be skin permeable, presumably due to the nano-bio interaction with skin lipids and the consequent induction of transient and reversible openings on the stratum corneum. Importantly, when simultaneously applied with Au-NPs, the protein drugs were also granted the ability to penetrate the skin barrier and migrate into the deep layers. This indicated that co-administration with the skin-permeable Au-NPs could mediate proteins across the skin barrier. Such co-delivery effect highlights a simple yet effective method for overcoming the skin barrier for percutaneous protein drug delivery. Employing this method, a non-invasive vaccine delivery strategy was developed, and by topically co-administrating antigens with Au-NPs, robust immune responses were elicited in the tested animals. The results provide the promise for achieving a needleless and self-administrable transcutaneous vaccination.

Indexed as

Drug Delivery SystemsAdministration, CutaneousAnimalsCell DeathGoldHumansImmunizationKeratinocytesMetal NanoparticlesMiceMice, Inbred BALB COvalbuminParticle SizeProteinsSkin AbsorptionGoldOvalbuminProteins

Identifiers

PMID20828812
PMCPMC2949472
OpenAlexW2019096170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.